Scientists report “unprecedented” success using T-cells to treat late stage Cancer

T-cells are our body’s natural protectors against viruses and foreign cells, but cancer often grows too quickly and overwhelms them. In immunotherapy, T-cells are reprogrammed act aggressively towards the cancer cells, and the early clinical trials show promise for late-stage patients.